What's breaking now, across thousands of outlets.
A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
Inhibrx Biosciences says its latest mid-stage results show the potential of its OX40 agonist in immunogenic cancers — but also its prospects in combination with cancer vaccines in tumors with lower…
“Pushing this is like a rock up a hill, because there’s been so much failure in the space,” said Inhibrx CEO Mark Lappe.
Maharashtra is eyeing a larger role in global healthcare innovation by leveraging the India-UK CETA to attract investment, technology and partnerships, with the state’s strong pharma, medtech and…
Despite nearly 1.3 million deaths and counting, there is still not a national memorial for the pandemic. Our informal memorial in the middle of the Mojave Desert is one small way to remember those…
Patients of disgraced brain surgeon Sam Eljamel were left with "horrific" disabilities following his operations, a former MSP has told an inquiry.
Kids with obesity-related conditions like high cholesterol or sleep apnea were substantially more likely to be prescribed GLP-1s than those without.
